REPORT ID 13804

United States Tigecycline Market Report 2017

Publish Date
22-Nov-17
Pages
105
Format
Electronic (PDF)

In this report, the United States Tigecycline market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Tigecycline in these regions, from 2012 to 2022 (forecast).

United States Tigecycline market competition by top manufacturers/players, with Tigecycline sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Pfizer
    Hisun Pharma
    Hansoh Pharma
    Jiagsu Aosaikang Pharmaceutical
    HICIN Pharma
    Abbott Laboratories
    Amgen
    Astrazeneca
    Merck
    Novartis
    Roche Holdings
    Johnson & Johnson
    Sanofi
    Lifecare Innovations
    Progen Nutraceuticals

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Gram Positive Bacteria
    Gram Negative Bacteria
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Skin & Soft Tissue Infections
    Complicated Intra-abdominal Infections
    Community-acquired Bacterial Pneumonia

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Tigecycline Market Report 2017
1 Tigecycline Overview
    1.1 Product Overview and Scope of Tigecycline
    1.2 Classification of Tigecycline by Product Category
        1.2.1 United States Tigecycline Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Tigecycline Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Gram Positive Bacteria
        1.2.4 Gram Negative Bacteria
    1.3 United States Tigecycline Market by Application/End Users
        1.3.1 United States Tigecycline Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Skin & Soft Tissue Infections
        1.3.3 Complicated Intra-abdominal Infections
        1.3.4 Community-acquired Bacterial Pneumonia
    1.4 United States Tigecycline Market by Region
        1.4.1 United States Tigecycline Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Tigecycline Status and Prospect (2012-2022)
        1.4.3 Southwest Tigecycline Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Tigecycline Status and Prospect (2012-2022)
        1.4.5 New England Tigecycline Status and Prospect (2012-2022)
        1.4.6 The South Tigecycline Status and Prospect (2012-2022)
        1.4.7 The Midwest Tigecycline Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Tigecycline (2012-2022)
        1.5.1 United States Tigecycline Sales and Growth Rate (2012-2022)
        1.5.2 United States Tigecycline Revenue and Growth Rate (2012-2022)

2 United States Tigecycline Market Competition by Players/Suppliers
    2.1 United States Tigecycline Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Tigecycline Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Tigecycline Average Price by Players/Suppliers (2012-2017)
    2.4 United States Tigecycline Market Competitive Situation and Trends
        2.4.1 United States Tigecycline Market Concentration Rate
        2.4.2 United States Tigecycline Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Tigecycline Manufacturing Base Distribution, Sales Area, Product Type

3 United States Tigecycline Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Tigecycline Sales and Market Share by Region (2012-2017)
    3.2 United States Tigecycline Revenue and Market Share by Region (2012-2017)
    3.3 United States Tigecycline Price by Region (2012-2017)

4 United States Tigecycline Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Tigecycline Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Tigecycline Revenue and Market Share by Type (2012-2017)
    4.3 United States Tigecycline Price by Type (2012-2017)
    4.4 United States Tigecycline Sales Growth Rate by Type (2012-2017)

5 United States Tigecycline Sales (Volume) by Application (2012-2017)
    5.1 United States Tigecycline Sales and Market Share by Application (2012-2017)
    5.2 United States Tigecycline Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Tigecycline Players/Suppliers Profiles and Sales Data
    6.1 Pfizer
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Tigecycline Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Pfizer Tigecycline Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Hisun Pharma
        6.2.2 Tigecycline Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Hisun Pharma Tigecycline Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Hansoh Pharma
        6.3.2 Tigecycline Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Hansoh Pharma Tigecycline Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Jiagsu Aosaikang Pharmaceutical
        6.4.2 Tigecycline Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Jiagsu Aosaikang Pharmaceutical Tigecycline Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 HICIN Pharma
        6.5.2 Tigecycline Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 HICIN Pharma Tigecycline Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Abbott Laboratories
        6.6.2 Tigecycline Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Abbott Laboratories Tigecycline Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Amgen
        6.7.2 Tigecycline Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Amgen Tigecycline Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Astrazeneca
        6.8.2 Tigecycline Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Astrazeneca Tigecycline Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Merck
        6.9.2 Tigecycline Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Merck Tigecycline Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Novartis
        6.10.2 Tigecycline Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Novartis Tigecycline Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Roche Holdings
    6.12 Johnson & Johnson
    6.13 Sanofi
    6.14 Lifecare Innovations
    6.15 Progen Nutraceuticals

7 Tigecycline Manufacturing Cost Analysis
    7.1 Tigecycline Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Tigecycline

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Tigecycline Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Tigecycline Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Tigecycline Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Tigecycline Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Tigecycline Sales Volume Forecast by Type (2017-2022)
    11.3 United States Tigecycline Sales Volume Forecast by Application (2017-2022)
    11.4 United States Tigecycline Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer